The Convergence of Dopamine and α-Synuclein: Implications for Parkinson’s Disease

by Danielle E Mor, Harry Ischiropoulos
Published 2018-03-01

Mitochondrial hyperactivity as a potential therapeutic target in Parkinson’s disease

by Danielle E. Mor, Coleen T. Murphy
Published 2020-01-01

High-throughput behavioral screen in C. elegans reveals Parkinson’s disease drug candidates

by Salman Sohrabi, Danielle E. Mor, Rachel Kaletsky, William Keyes, Coleen T. Murphy
Published 2021-02-01

Dynamic structural flexibility of α-synuclein

by Danielle E. Mor, Scott E. Ugras, Malcolm J. Daniels, Harry Ischiropoulos
Published 2016-04-01

CXCL12-mediated guidance of migrating embryonic stem cell-derived neural progenitors transplanted into the hippocampus.

by Nathaniel W Hartman, Joseph E Carpentino, Kristi LaMonica, Danielle E Mor, Janice R Naegele, Laura Grabel
Published 2010-01-01